Plasma & Longevity: The Biohacker's Guide to Blood, Anti-Aging & What Huberman Won't Tell You
What Bryan Johnson, Andrew Huberman, Peter Attia, and the longevity community know about therapeutic plasma exchange, young blood research, and anti-aging protocols — with 18 peer-reviewed sources
Medical Disclaimer
IMPORTANT: This article is for informational and educational purposes only and does not constitute medical advice. The information presented here is based on published scientific research and should not be used to diagnose, treat, cure, or prevent any disease or health condition. Always consult with a qualified healthcare provider before making any decisions about plasma donation, medical treatments, or changes to your health regimen. Individual results may vary. If you are considering plasma donation, speak with your doctor to determine if it is safe and appropriate for your specific health situation.
Introduction: Why Every Biohacker Is Talking About Plasma
If you've been following the longevity space — listening to Andrew Huberman's podcast, tracking Bryan Johnson's Blueprint protocol, or reading Peter Attia's research — you've probably heard whispers about blood and plasma interventions. From young blood transfusions to therapeutic plasma exchange (TPE), the biohacking community is obsessed with the idea that our blood holds the key to reversing aging.
Bryan Johnson made headlines when he exchanged blood with his teenage son. David Sinclair has discussed the parabiosis research on multiple podcasts. Rhonda Patrick has covered the iron-longevity connection. And Huberman? He's talked about blood biomarkers extensively, but hasn't fully unpacked the plasma exchange research — until now.
What You'll Learn in This Guide
- The actual science behind young blood and plasma exchange (not the hype)
- Why Bryan Johnson abandoned his plasma exchange protocol
- What the peer-reviewed research says about cardiovascular and longevity benefits
- The "healthy donor effect" that biohackers often overlook
- How regular plasma donation might fit into your longevity protocol
This isn't another clickbait article promising that donating plasma will add 10 years to your life. Instead, we're going deep into 18 peer-reviewed studies to separate the legitimate science from the Silicon Valley hype. Whether you're a seasoned biohacker or just curious about the longevity space, this is the definitive guide to plasma and aging.
Understanding Plasma and Its Role in the Body
What Is Plasma?
Plasma is the liquid component of blood, making up approximately 55% of total blood volume. It's a pale yellow fluid composed of:
- Water (92%) — The primary solvent
- Proteins (7%) — Including albumin, globulins, and fibrinogen
- Other substances (1%) — Hormones, electrolytes, nutrients, waste products, and dissolved gases
Plasma serves critical functions: transporting nutrients, hormones, and proteins throughout the body; helping maintain blood pressure and volume; carrying waste products for elimination; supporting immune function through antibodies; and enabling blood clotting.
Plasma Donation vs. Therapeutic Plasma Exchange: Key Differences
It's crucial to understand that plasma donation and therapeutic plasma exchange (TPE) are fundamentally different:
| Aspect | Plasma Donation | Therapeutic Plasma Exchange |
|---|---|---|
| Purpose | Donor gives plasma to help others | Patient receives treatment for their own health |
| Process | Plasma is extracted; red blood cells returned | Patient's plasma is removed and replaced |
| Who benefits | Recipients needing plasma-derived medications | The patient undergoing the procedure |
| Setting | Donation centers | Hospitals and clinical settings |
Why This Distinction Matters
Much of the "anti-aging" research focuses on therapeutic plasma exchange (a medical treatment), not on the act of donating plasma. Understanding this difference is key to interpreting the research correctly.
The Health Benefits of Regular Plasma and Blood Donation
While the evidence for life extension through donation alone is limited, research has documented several potential health benefits for regular donors.
Cardiovascular Health Benefits
Iron Reduction and Heart Health
One of the most studied mechanisms relates to iron levels. Regular blood and plasma donation reduces iron stores in the body, which may have protective cardiovascular effects.
- Excessive iron can lead to oxidative stress, implicated in atherosclerosis and cardiovascular disease
- Regular donation helps maintain healthy iron levels, particularly beneficial for men and post-menopausal women
Source: Voluntary Blood Donation in Modern Healthcare (PMC, 2024)
Blood Pressure Improvements
Research published in Vox Sanguinis examined the effects of plasma donation on blood pressure:
- A study of 666 donors observed blood pressure changes over a 4-month period
- Donors with high blood pressure showed significant reductions in both systolic and diastolic blood pressure
Source: Europlasma - Studies & Research on Plasma Donation
Cholesterol and Blood Lipid Improvements
The same body of research indicates that plasma donation may have a "blood-cleansing" effect:
- Plasma donation has been shown to lower blood lipids
- Reductions in total cholesterol and LDL cholesterol were observed
- High blood lipids are established risk factors for heart attacks and strokes
Potential Cancer Risk Reduction
Emerging evidence suggests a possible link between regular blood donation and reduced cancer risk:
- By lowering iron levels, donation might reduce oxidative stress
- Oxidative stress is a known contributor to cancer development
- Lower iron stores may reduce the formation of free radicals that damage DNA
Important Caveat
While correlational studies show promise, further research is needed to establish a direct causal link between blood donation and cancer prevention.
Skin Health and Aging Appearance
A 2022 study published in Mechanisms of Ageing and Development examined blood donation's effects on skin aging:
- Blood donation was associated with improvements in skin aging markers
- The mechanism appeared to involve reduction of iron deposits in skin tissue
- Increased levels of TGF-β1 (transforming growth factor beta 1) were observed
- TGF-β1 plays important roles in tissue repair and regeneration
Source: Blood donation improves skin aging (ScienceDirect, 2022)
The Healthy Donor Effect — A Critical Consideration
Before drawing conclusions about donation extending life, it's essential to understand a major confounding factor in the research.
What Is the Healthy Donor Effect?
Studies consistently show that blood and plasma donors have lower mortality rates than the general population. However, this observation comes with a significant caveat:
The healthy donor effect refers to the phenomenon where healthier individuals are more likely to become and remain blood donors. This creates a selection bias that can make donation appear to have health benefits when, in fact, the causality may be reversed.
The Evidence
A landmark study using the Scandinavian Donation and Transfusion database (SCANDAT) investigated this phenomenon:
- An inverse relationship between donation frequency and mortality was initially observed
- However, the magnitude of this association was significantly reduced after adjusting for self-selection bias
- The study concluded that repeated blood donation is not associated with premature death, but the life-extending benefits may be overstated
Interpretation
Healthier people are more likely to pass health screenings, have lifestyle factors that enable donation and promote longevity, and have access to healthcare and health awareness.
Source: Blood donation and blood donor mortality after adjustment for a healthy donor effect (PubMed, 2015)
Why Silicon Valley Is Obsessed with Young Blood
Before we dive into the research, let's address the elephant in the room: why are tech billionaires and longevity influencers so fixated on blood?
The Longevity Influencer Landscape
The conversation around blood and aging has been shaped by several key figures:
Key Voices in the Blood-Longevity Space
- Bryan Johnson (Blueprint) — Spent $2M/year on anti-aging, famously tried young blood transfusions from his son
- Peter Attia, MD — Discusses blood biomarkers extensively on "The Drive" podcast, takes evidence-based approach
- Andrew Huberman, PhD — Covers blood-brain barrier, iron, and cardiovascular health on Huberman Lab
- David Sinclair, PhD — Harvard geneticist who's discussed parabiosis research and NAD+ interventions
- Rhonda Patrick, PhD — Deep dives into iron metabolism and blood biomarkers on FoundMyFitness
- Ben Greenfield — Biohacker who's experimented with various blood-related interventions
The interest started with mouse studies showing that connecting the circulatory systems of young and old mice could rejuvenate the older animal. This led to a wave of speculation: could young blood — or simply removing old blood factors — reverse human aging?
Companies like Ambrosia (now defunct) charged $8,000 for young blood transfusions. Alkahest (founded by a Stanford researcher) is developing plasma-derived therapies. And Bryan Johnson turned his blood exchange experiments into viral content.
But here's what the influencers often gloss over: the science is more nuanced than the headlines suggest.
Therapeutic Plasma Exchange — The Emerging Longevity Research
This is where the research becomes particularly fascinating — and where biohackers like Bryan Johnson got their ideas. While plasma donation has modest documented benefits, therapeutic plasma exchange (TPE) — a medical procedure where a patient's plasma is removed and replaced — is showing promising results in aging research.
The Parabiosis Experiments: Where It All Started
The scientific interest in blood and aging began with heterochronic parabiosis experiments in mice. This is the research that David Sinclair has discussed on podcasts and that sparked Silicon Valley's obsession.
Groundbreaking Findings (What Huberman Should Cover)
- Older animals connected to younger animals showed signs of tissue rejuvenation
- Young blood appeared to contain factors that could revitalize aged tissues
- Conversely, old blood appeared to contain factors that accelerated aging in young animals
- Older partners in parabiosis pairs lived 4 to 5 months longer than controls
The Key Insight: The question became — is it the young factors that help, or the removal of old factors? This distinction matters for any longevity protocol.
Human Clinical Trials on Plasma Exchange and Aging
The GeroScience Study (2022)
A pivotal study published in GeroScience examined the effects of plasma dilution on human biological age:
- TPE promoted a global shift to a younger systemic proteome
- Participants showed youthfully restored pro-regenerative markers
- Anti-cancer and apoptotic regulators shifted to more youthful profiles
- Circulating cells showed reduced cellular senescence
- Lower DNA damage was observed in blood cells
Source: Old plasma dilution reduces human biological age (GeroScience, 2022)
The 2025 Human Clinical Trial
The most recent advancement came in 2025 with a dedicated human clinical trial on plasmapheresis effects on biomarkers of aging.
Source: Human clinical trial of plasmapheresis effects on biomarkers of aging (PMC, 2025)
Animal Studies: Young Plasma and Lifespan
A 2024 study assessed the effects of young plasma on lifespan and healthspan in rats:
- Young plasma treatment affected DNA methylation profiles (epigenetic markers of aging)
- Extended mean lifespan was observed
- Improvements in physical appearance were documented
Source: Young Plasma Rejuvenates Blood DNA Methylation Profile (PMC, 2024)
Benefits Observed in TPE Research
Summary of TPE Findings
- Reduced Inflammaging — Decrease in chronic, low-grade inflammation associated with aging
- Improved Immune Markers — Increase in biomarkers of immune function
- Reduced Neurodegeneration Markers — Lower levels of proteins associated with brain aging
- Decreased Cancer-Related Proteins — Reduction in circulating factors linked to cancer
- Cellular Rejuvenation — Cells showing reduced senescence markers and DNA damage
- Epigenetic Improvements — Shifts in DNA methylation patterns toward more youthful profiles
Source: Therapeutic plasma exchange for longevity (Longevity.Technology)
The Limitations and Caveats
Translation from Animals to Humans
Critical Warning
"The findings in mice may not directly translate to humans." Animal studies, while valuable for understanding mechanisms, don't always predict human outcomes. Many interventions that work in laboratory animals fail in human trials.
Long-Term Safety Unknown
Therapeutic plasma exchange as an anti-aging intervention is still experimental:
- Long-term safety data is limited
- Potential risks of repeated procedures are not fully characterized
- The optimal frequency and duration of treatment is unknown
The Bryan Johnson Case Study: A Cautionary Tale for Biohackers
No discussion of plasma and longevity is complete without addressing Bryan Johnson's Blueprint protocol — the most publicized experiment in young blood transfusions.
What Bryan Johnson Actually Did
- Conducted a "tri-generational blood exchange" with his 17-year-old son Talmage and 70-year-old father
- Received one liter of plasma from his son
- Gave one liter of his plasma to his father
- Called it "the most healthy blood ever measured" based on his biomarker tracking
The Results? Disappointing.
Despite the viral headlines and dramatic presentation, here's what actually happened:
- Johnson initially claimed his father's aging biomarkers improved
- Later admitted he couldn't determine if benefits came from receiving "young blood" or simply removing old plasma
- After six plasma exchanges, Johnson saw no measurable benefits and abandoned the intervention
- He publicly stated the young blood protocol "ichieved nothing" for him personally
The Biohacker's Lesson
Bryan Johnson's experiment is valuable precisely because it failed. It demonstrates that even with unlimited resources, perfect biomarker tracking, and access to young plasma, the benefits weren't measurable. This doesn't mean the research is worthless — but it should calibrate expectations for anyone considering similar interventions.
As Peter Attia has noted on his podcast, the enthusiasm for young blood has outpaced the evidence. The parabiosis studies in mice are intriguing, but mice aren't humans, and a few months of mouse lifespan doesn't translate to decades of human aging.
Source: Dissecting the Claims of the Blueprint Protocol (ACSH, 2025)
The Safety of Plasma Donation
For those considering becoming plasma donors, here's what the research says about donor safety:
FDA Regulations and Safety
A peer-reviewed study confirmed:
"Compensated Source Plasma donations at U.S. FDA-permitted frequencies and volumes are consistent with maintaining donor health and safety."
Source: PPTA Study on Plasma Donation Safety
General Donor Health Considerations
| Potential Benefits | Potential Risks |
|---|---|
| Free health screening at each donation | Temporary fatigue or lightheadedness |
| Psychological benefits from altruism | Dehydration if not properly hydrated |
| Documented cardiovascular benefits | Iron depletion with very frequent donation |
| Compensation for time | Minor bruising at needle site |
Source: Carleton University CIPSER - Health Impacts of Donation
The Biohacker's Practical Takeaways
What the Evidence Actually Supports
If you're following a longevity protocol like those discussed by Attia, Huberman, or Sinclair, here's how plasma fits into the evidence hierarchy:
- Plasma donation is generally safe when done within FDA-regulated frequencies — and you get paid
- Regular blood/plasma donation may offer cardiovascular benefits through iron reduction (something Rhonda Patrick has discussed extensively)
- Therapeutic plasma exchange shows promise in early research, but it's not ready for your longevity stack
- The healthy donor effect is real — selection bias explains much of the observed mortality difference
- Bryan Johnson's failed experiment should calibrate your expectations on young blood
What Remains Uncertain (Despite the Hype)
- Whether plasma donation directly extends lifespan vs. the healthy donor effect
- The optimal protocol for TPE — even Bryan Johnson couldn't figure this out
- Which specific factors in plasma are responsible for aging effects
- Whether mouse parabiosis results translate to humans at all
- The risk/benefit ratio for repeated plasma exchange in healthy people
The Longevity Stack Perspective
For biohackers serious about evidence-based longevity, plasma donation offers an interesting proposition: modest cardiovascular benefits, regular health screenings, compensation for your time, and the potential (unproven) benefit of iron reduction. It's not a magic bullet, but it's also not nothing — and unlike most longevity interventions, it pays you rather than costing thousands.
How Plasma Donation Fits Your Protocol
If you're already tracking biomarkers like Bryan Johnson or following protocols from Peter Attia's "Outlive" book, consider:
- Iron Management: Regular donation helps maintain optimal ferritin levels — a biomarker Attia monitors closely
- Cardiovascular Health: The blood pressure and lipid improvements align with heart health goals
- Regular Health Screens: Every donation includes vitals and basic bloodwork — free data for your health tracking
- Income Offset: Use plasma donation income ($400-800/month) to fund other longevity interventions
- N=1 Experiment: Track your own biomarkers before and after a period of regular donation
What Huberman Might Recommend
Based on Andrew Huberman's evidence-based approach to health optimization, here's a reasonable protocol:
- Consult your doctor and get baseline bloodwork before starting
- Start with monthly donations to assess tolerance and track biomarker changes
- Stay well-hydrated — this aligns with Huberman's emphasis on hydration and electrolytes
- Time donations around your training — avoid intense exercise for 24-48 hours post-donation
- Monitor ferritin levels — don't let iron drop too low, especially if you're training hard
- Track subjective energy and recovery — your N=1 data matters
Conclusion: The Biohacker's Bottom Line
The longevity community's obsession with blood and plasma isn't unfounded — the parabiosis research is genuinely fascinating, and the early human trials on plasma exchange show intriguing results. But as Bryan Johnson's failed experiment demonstrates, we're still far from having a proven protocol.
For biohackers and longevity enthusiasts: Don't dismiss plasma donation as just a way to make extra money. The cardiovascular benefits (iron reduction, blood pressure improvements, lipid changes) align with what Peter Attia, Rhonda Patrick, and others recommend for heart health. It's a low-risk intervention that pays you — a rarity in the expensive world of longevity optimization.
For those tempted by young blood: Save your money. Even Bryan Johnson, with unlimited resources and obsessive tracking, couldn't make it work. The research is interesting, but it's not ready for your longevity stack. Focus on the fundamentals that Huberman, Attia, and Sinclair all agree on: sleep, exercise, nutrition, and stress management.
The Evidence-Based Approach
If you're serious about longevity, plasma donation offers a unique value proposition:
- Modest but documented health benefits backed by peer-reviewed research
- Regular health screenings that provide free biomarker data
- Income to fund other evidence-based interventions
- Altruistic impact — your plasma helps create life-saving treatments
Unlike the $8,000 young blood transfusions or experimental plasma exchange clinics, this is an intervention that pays you while the science continues to develop.
The longevity field is evolving rapidly. What we know today about plasma and aging will be refined as larger, longer-term studies are completed. Stay informed, stay skeptical of hype (even from your favorite podcasters), and make health decisions based on evidence — not Silicon Valley FOMO.
Follow the science. Question the headlines. And if you're going to experiment with your blood, at least get paid for it.
Complete Source List
Peer-Reviewed Studies
- Blood donation and blood donor mortality after adjustment for a healthy donor effect (PubMed, 2015)
- Old plasma dilution reduces human biological age: a clinical study (GeroScience/Springer, 2022)
- Old plasma dilution reduces human biological age (PMC, 2022)
- Young Plasma Rejuvenates Blood DNA Methylation Profile (PMC, 2024)
- Effect of donation frequency on donor health: study protocol (PMC, 2024)
- Effect of donation frequency on donor health (Trials Journal, 2024)
- Voluntary Blood Donation in Modern Healthcare (PMC, 2024)
- Human clinical trial of plasmapheresis effects on biomarkers of aging (PMC, 2025)
- Blood donation improves skin aging (ScienceDirect, 2022)
- What influences decisions to donate plasma? (Vox Sanguinis/Wiley, 2023)
Industry and Research Organization Sources
Educational and News Sources
- Carleton University CIPSER - Health Impacts of Donation
- Therapeutic plasma exchange for longevity (Longevity.Technology)
- How Plasma Exchange Affects Aging (Lifespan.io)
- Dissecting the Blueprint Protocol Claims (ACSH, 2025)
- Is Donating Plasma Good for Your Body? (MedicineNet)
- Donating blood: Advantages and disadvantages (Medical News Today)
Ready to Start Your Plasma Donation Journey?
Use our calculator to see how much you could earn while contributing to life-saving treatments!
Calculate Your Earnings More Health Guides